Side-by-side comparison of AI visibility scores, market position, and capabilities
Santiago digital healthcare marketplace connecting LatAm patients with home labs, telemedicine, and specialist booking at $14.9M revenue; YC-backed with M&A offer received April 2025 across Chile, Mexico, Colombia.
Examedi is a Santiago, Chile-based digital healthcare marketplace — backed by Y Combinator with $14.9 million in revenue in 2024, having received an M&A offer in April 2025 — connecting patients across Latin America with on-demand healthcare services including lab testing at home, telemedicine consultations, home nursing visits, and specialist appointments through a marketplace model that coordinates healthcare workers, labs, and facilities. Founded in 2021 by Andres Kemeny and Juan Pablo Zepeda, Examedi serves patients, employers, health plans, and healthcare facilities throughout Chile, Mexico, Colombia, and broader Latin America as a healthcare access intermediary.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.